Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
TNF receptor superfamily member 11b | 0.422 | 0.808 | 0.16 |
|
disease | 0.400 | None | 0.929 | 3 | 0 | 2001 | 2019 | ||||||||
|
solute carrier family 11 member 1 | 0.525 | 0.846 | 1.5E-19 |
|
disease | 0.400 | None | 0.938 | 3 | 0 | 1996 | 2019 | ||||||||
|
interleukin 1 receptor antagonist | 0.373 | 0.923 | 3.1E-02 |
|
disease | 0.400 | None | 0.947 | 3 | 0 | 1992 | 2020 | ||||||||
|
adiponectin, C1Q and collagen domain containing | 0.376 | 0.885 | 4.6E-09 |
|
disease | 0.400 | None | 0.957 | 3 | 0 | 2003 | 2020 | ||||||||
|
C-X-C motif chemokine ligand 8 | 0.310 | 0.962 | 2.7E-04 |
|
disease | 0.400 | None | 0.968 | 2 | 0 | 1990 | 2020 | ||||||||
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
disease | 0.400 | None | 0.987 | 2 | 0 | 1994 | 2020 | ||||||||
|
interleukin 23 subunit alpha | 0.415 | 0.846 | 0.36 |
|
disease | 0.400 | None | 1.000 | 2 | 0 | 1989 | 2020 | ||||||||
|
interferon gamma | 0.288 | 0.962 | 0.47 |
|
disease | 0.400 | None | 0.947 | 2 | 0 | 1990 | 2020 | ||||||||
|
C-C motif chemokine ligand 21 | 0.502 | 0.769 | 3.6E-02 |
|
disease | 0.400 | None | 0.857 | 2 | 0 | 2003 | 2019 | ||||||||
|
toll like receptor 2 | 0.361 | 0.923 | 1.0E-06 |
|
disease | 0.400 | None | 0.966 | 2 | 0 | 2003 | 2019 | ||||||||
|
cellular communication network factor 1 | 0.473 | 0.731 | 0.71 |
|
disease | 0.400 | None | 0.929 | 1 | 0 | 2006 | 2019 | ||||||||
|
enolase 1 | 0.481 | 0.885 | 1.9E-05 |
|
disease | 0.400 | None | 0.905 | 1 | 0 | 2008 | 2019 | ||||||||
|
catalase | 0.359 | 0.962 | 1.6E-10 |
|
disease | 0.400 | None | 0.917 | 1 | 0 | 2006 | 2019 | ||||||||
|
C-X-C motif chemokine receptor 4 | 0.362 | 0.923 | 1.8E-02 |
|
disease | 0.400 | None | 0.944 | 1 | 0 | 2000 | 2019 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
disease | 0.400 | None | 0.952 | 1 | 0 | 1994 | 2019 | ||||||||
|
matrix metallopeptidase 2 | 0.333 | 0.923 | 0.84 |
|
disease | 0.400 | None | 0.923 | 1 | 0 | 1998 | 2019 | ||||||||
|
aggrecan | 0.528 | 0.846 | 1.00 |
|
disease | 0.400 | None | 1.000 | 1 | 0 | 1998 | 2019 | ||||||||
|
paraoxonase 1 | 0.409 | 0.885 | 9.8E-11 |
|
disease | 0.400 | None | 0.917 | 1 | 0 | 2003 | 2019 | ||||||||
|
TNF superfamily member 14 | 0.529 | 0.769 | 5.2E-02 |
|
disease | 0.390 | None | 1.000 | 1 | 0 | 2003 | 2017 | ||||||||
|
TNF receptor superfamily member 14 | 0.568 | 0.731 | 0.81 |
|
disease | 0.380 | None | 0.889 | 1 | 0 | 2003 | 2017 | ||||||||
|
collagen type II alpha 1 chain | 0.444 | 0.846 | 1.00 |
|
disease | 0.350 | None | 0.857 | 3 | 0 | 1993 | 2018 | ||||||||
|
prostaglandin-endoperoxide synthase 1 | 0.460 | 0.885 | 6.2E-07 |
|
disease | 0.340 | None | 1.000 | 1 | 0 | 1994 | 2004 | ||||||||
|
5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase | 0.576 | 0.731 | 3.0E-19 |
|
disease | 0.340 | None | 1.000 | 1 | 0 | 2004 | 2016 | ||||||||
|
Fas ligand | 0.430 | 0.885 | 0.18 |
|
disease | 0.340 | None | 1.000 | 1 | 0 | 2008 | 2015 | ||||||||
|
CD83 molecule | 0.566 | 0.731 | 5.2E-03 |
|
disease | 0.330 | None | 0.750 | 1 | 0 | 2003 | 2017 |